trending Market Intelligence /marketintelligence/en/news-insights/trending/4iqs5fsg6nrjvwlsuajexa2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

UnitedHealth sued over alleged scheme to overcharge customers for prescription drugs

Mobile Payment Apps Driving Fintech Frenzy In India

Street Talk Episode 42: Banks losing consumer deposits to fintech, digital platforms, commercial might be next

Corporate Renewables Market Looks To Continue Growth After Record 2018

Reframing The Conversation Around Cyber Risk


UnitedHealth sued over alleged scheme to overcharge customers for prescription drugs

UnitedHealthGroup Inc. customers have filed a class-actioncomplaint against the insurer for extracting payments for prescription drugsbeyond the drugs' actual cost.

According to the complaint, UnitedHealth would instructpharmacies to charge customers a copayment beyond the drug's cost, then collectthe spread between the two prices.

Since the insurer was already compensated for providing drugbenefits through the premiums paid by customers, "their taking ofadditional, undisclosed Spread compensation was improper and illegal under [theEmployee Retirement Income Security Act] and [the Racketeering Influenced andCorrupt Organizations Act]," the complaint states.

The complaint was filed in a Minnesota federal court. AnnaMohr, Samantha Sohmer and Charles Wiltsie are the lead plaintiffs on behalf ofthe class.

The complaint seeks treble damages for the plaintiffs andnationwide class, plus legal fees and expenses. A jury trial has been demanded.

UnitedHealth did not respond to a request for comment.